• Capobianco N, Meignan M, Cottereau AS, Vercellino L, Sibille L, Spottiswoode B, Zuehlsdorff S, Casasnovas O, Thieblemont C, Buvat I. Deep learning FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma. J Nucl Med. 2020. in press.

  • Wimberley C, Nguyen DL, Truillet C, Peyronneau MA, Gulhan Z, Tonietto M, Boumezbeur F, Boisgard R, Chalon S, Bouilleret V, Buvat I. Longitudinal mouse-PET imaging: a reliable method for estimating binding parameters without a reference region or blood sampling. Eur J Nucl Med Mol Imaging. 2020. in press.

  • Zwanenburg A, Vallières M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga RJ, Boellaard R, Bogowicz M, Boldrini L, Buvat I, Cook GJR, Davatzikos C, Depeursinge A, Desseroit MC, Dinapoli N, Dinh CV, Echegaray V, El Naqa I, Fedorov AY, Gatta R, Gillies RJ, Goh V, Guckenberger M, Götz M, Ha SM, Hatt M, Isensee F, Lambin P, Leger S, Leijenaar RTH, Lenkowicz J, Lippert F, Losnegård A, Maier-Hein KH, Morin O, Müller H, Napel S, Nioche C, Orlhac F, Pati S, Pfaehler EAG, Rahmim A, Rao AUK, Scherer J, Siddique MM, Sijtsema NM, Fernandez JS, Spezi E, Steenbakkers RJHM, Tanadini-Lang S, Thorwarth D, Troost EGC, Upadhaya T, Valentini C, van Dijk LV, van Griethuysen J, van Velden FHP, Whybra P, Richter C, Löck S. The Image Biomarker Standardization Initiative: standardized quantitative radiomics for highthroughput image-based phenotyping. Radiology. 2020. in press.

  • Tanaka I, Chakraborty A, Saulnier O, Benoit-Pilven C, Vacher S, Labiod D, Lam EWF, Bièche I, Delattre O, Pouzoulet F, Auboeuf D, Vagner S, Dutertre M. ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin. Nucleic Acids Res. 2020 Jan 16. pii: gkz1213. 

  • Lacroix M, Frouin F, Dirand AS, Nioche C, Orlhac F, Bernaudin JF, Brillet PY, Buvat I. Correction for magnetic field inhomogeneities and normalization of voxel values are needed to better reveal the potential of MR radiomic features in lung cancer. Front Oncol. doi: 10.3389/fonc.2020.00043, 2020.

  • Cottereau AS, Nioche C, Dirand AS, Clerc J, Morschhauser F, Casasnovas O, Meignan MA, Buvat I. 18F-FDG-PET dissemination features in diffuse large B cell lymphoma are predictive of outcome. J Nucl Med. 61. 40-45, 2020.

  • Provost C, Mammar H, Belly-Poinsignon A, Madar O, Champion L. Pharmacokinetic Analysis of [18F]FAZA Dynamic PET Imaging Acquisitions for Highlighting Sacrum Tumor Profiles. Clin Nucl Med. 45:e36-e38, 2020. 

  • Boughdad S, Nioche C, Orlhac F, Jehl L, Champion L, Buvat I. Influence of age on radiomic features in 18F-FDG PET in normal breast tissue and in breast cancer tumors. Oncotarget. 9:30855-30868, 2018. version PDF

  • Goutal S, Gerstenmayer M, Auvity S, Caillé F, Mériaux S, Buvat I, Larrat B, Tournier N. Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib. J Control Release. 292:210-220, 2018.

  • Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, Barakat C, Soussan M, Frouin F, Buvat I. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 78:4786-4789, 2018. version PDF

  • Reuzé S, Schernberg A, Orlhac F, Sun R, Dercle L, Deutsch E, Buvat I, Robert C. Radiomics in Nuclear Medicine applied to Radiation Therapy: methods, pitfalls and challenges. Int J Radiat Oncol Biol Phys. 102:1117-1142, 2018. version PDF

  • Auvity S, Caillé F, Marie S, Wimberley C, Bauer M, Langer O, Buvat I, Goutal S, Tournier N. P-glycoprotein (ABCB1) inhibits the influx and increases the efflux of 11C-metoclopramide across the blood-brain barrier: a PET study on non-human primates. J Nucl Med. 59:1609-1615, 2018.

  • Goya-Outi J, Orlhac F, Calmon R, Alentorn A, Nioche C, Philippe C, Puget S, Boddaert N, Buvat I, Grill J, Frouin V, Frouin F. Computation of reliable textural indices from multimodal brain MRI: suggestions based on a study of patients with diffuse intrinsic pontine glioma. Phys Med Biol. 63:105003, 2018. version PDF

  • Cottereau AS, Buvat I, Kanoun S, Versari A, Casasnovas O, Chauvie S, Clerc J, Gallamini A, Meignan M. Is there an optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma? Eur J Nucl Med Mol Imaging. 45:1463-1464, 2018. version PDF

  • Nguyen DL, Wimberley C, Truillet C, Jego B, Caillé F, Pottier G, Boisgard R, Buvat I, Bouilleret V. Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows. Epilepsia. 59:1234-1244, 2018. version PDF

  • Orlhac F, Boughdad S, Philippe C, Stalla-Bourdillon H, Nioche C, Champion L, Soussan M, Frouin F, Frouin V, Buvat I. A post-reconstruction harmonization method for multicenter radiomic studies in PET. J Nucl Med. 59:1321–1328, 2018. version PDF

  • Kucharczak F, Loquin K, Buvat I, Strauss O, Mariano-Goulart D. Interval-based reconstruction for uncertainty quantification in PET. Phys Med Biol. 63: 035014, 2018. version PDF

  • Wimberley C, Lavisse S, Peyronneau MA, Brulon V, Leroy C, Remy P, Stankoff B, Buvat I, Bottlaender M. The impact of endothelial TSPO on the quantification of 18F-DPA714 in the healthy human. J Nucl Med. 59: 307-314, 2018. version PDF

  • Schernberg A, Reuzé S, Orlhac F, Buvat I, Dercle L, Sun R, Limkin E, Escande A, Haie-Meder C, Deutsch E, Robert C. A score combining baseline neutrophilia and the SUVpeak of the primary tumor on FDG-PET predicts outcome in locally advanced cervical cancer. Eur J Nucl Med Mol Imaging. 45:187-195, 2018. version PDF

  • Saba W, Goutal S, Auvity S, Kuhnast B, Coulon C, Kouyoumdjian V, Buvat I, Leroy C, Tournier N. Imaging the neuroimmune response to alcohol exposure in adolescent baboons: a TSPO PET study using 18F-DPA-714. Addict Biol. 23:1000-1009, 2018.

  • Vandenberghe ME, Souedet N, Hérard AS, Ayral AM, Letronne F, Balbastre Y, Sadouni E, Hantraye P, Dhenain M, Frouin F, Lambert JC, Delzescaux T. Voxel-Based Statistical Analysis of 3D Immunostained Tissue Imaging. Front Neurosci. 12:754, 2018.

  • Lazard DS, Bergeret-Cassagne H, Lefort M, Leenhardt L, Russ G, Frouin F, Trésallet C. Transcutaneous Laryngeal Ultrasonography for Laryngeal Immobility Diagnosis in Patients with Voice Disorders After Thyroid/Parathyroid Surgery. World J Surg. 42:2102-2108, 2018.

  • Provost C, Prignon A, Rozenblum-Beddok L, Bruyer Q, Dumont S, Merabtene F, Nataf V, Bouteiller C, Talbot JN. Comparison and evaluation of two RGD peptides labelled with 68Ga or 18F for PET imaging of angiogenesis in animal models of human glioblastoma or lung carcinoma. Oncotarget. 9:19307-19316, 2018.

  • Buvat I, Orlhac F. The dark side of radiomics: on the paramount importance of publishing negative results. J Nucl Med. 60:1543-1544, 2019.

  • Dirand AS, Frouin F, Buvat I. A downsampling strategy to assess the predictive value of radiomic features. Sci Rep. 9:17869, 2019. version en ligne

  • Laurent C, Ricard L, Fain O, Buvat I, Adedjouma A, Soussan M, Mekinian A. PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity. Sci Rep. 9:12388, 2019. version en ligne

  • De Marzi L, Da Fonseca A, Moignier C, Patriarca A, Goudjil F, Mazal A, Buvat I, Hérault J. Experimental characterisation of a proton kernel model for pencil beam scanning techniques. Phys Med. 64:195-203, 2019. version PDF

  • Veit-Haibach I, Buvat I, Herrmann K. AI and Radiomics in Nuclear Medicine and Hybrid Imaging: potential, challenges and clinical role. Eur J Nucl Med Mol Imaging. 46: 2627-2629, 2019.

  • Orlhac F, Frouin F, Nioche C, Ayache N, Buvat I. Validation of a method to compensate multicenter effects affecting CT radiomic features. Radiology. 91:53-59, 2019.

  • Goldfarb L, Duchemann B, Chouahnia K, Zelek L, Soussan M. Monitoring anti-PD-L1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST. EJNMMI Res.9:8, 2019. version en ligne 

  • Prignon A, Provost C, Alshoukr F, Wendum D, Couvelard A, Barbet J, Forgez P, Talbot JN, Gruaz-Guyon A. Preclinical Evaluation of 68Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis. Mol Pharm. 16:2776-2784, 2019.

  • Provost C, Rozenblum-Beddok L, Nataf V, Merabtene F, Prignon A, Talbot JN. [68Ga]RGD Versus [18F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide. Mol Imaging Biol. 21:297-305, 2019.

  • Cassou-Mounat T, Champion L, Bozec L, Laurence V, Huchet V, Luporsi M, Jehanno N. Primary and Secondary Breast Angiosarcoma: FDG PET/CT Series. Clin Nucl Med. 44:e33-e35, 2019.

  • Bando-Delaunay A, Luporsi M, Huchet V, Cassou-Mounat T, Jehanno N. A Case of Sarcoidosis After Lymphoma. Clin Nucl Med. 44:646-647, 2019.

  • Jehanno N, Cassou-Mounat T, Mammar H, Luporsi M, Huchet V. 18F-Choline PET/CT Imaging for Intracranial Hemangiopericytoma Recurrence. Clin Nucl Med. 44:e305-e307, 2019.

  • Cassou-Mounat T, Luporsi M, Huchet V, Jehanno N. Gallbladder Metastasis From Conjunctival Melanoma. Clin Nucl Med. 44:e107-e109, 2019.